Corvus Pharmaceuticals, Inc.

CRVS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$9.70-3.29%

2026-11-02

Financials

Valuation Metrics

Corvus Pharmaceuticals, Inc.'s Market Cap is $816M. At end of 2025 it was $608M. Ranked #2504 of 3,116 in US market (top 80%), #1041 of 1,472 on NASDAQ (top 71%), #191 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 72%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$816M	US#2,504/3,116 Sec#191/265
Revenue	$0.00	US#2,859/3,116 Sec#193/265
Net Income	$-54M	US—/3,116 Sec—/265
Total Assets	$239M	US#2,950/3,116 Sec#232/265
Net Assets	$225M	US#2,625/3,116 Sec#175/265
Value
P/B	3.62x	US#1,999/3,116 Sec#118/265
FCF Yield	-5.54%	US—/3,116 Sec—/265
Profitability
ROE	-24.02%	US#2,513/3,116 Sec#104/265
ROA	-22.62%	US#2,817/3,116 Sec#137/265
Financial Health
Debt Ratio	6.19%	US#53/3,116 Sec#24/265
Total Debt	$728000.00	US#2,975/3,116 Sec#245/265
FCF	$-45M	US#2,512/3,116 Sec#111/265
Cash	$19M	US#2,869/3,116 Sec#257/265
Current Ratio	16.16x	US#150/3,116 Sec#43/265
Performance
1Y Return	20.65%	US#824/3,116 Sec#91/265
1M Return	-11.01%	US#2,688/3,116 Sec#210/265
From 52W High	-64.01%	US#2,898/3,116 Sec#228/265
1Y MDD	-63.24%	US#2,802/3,116 Sec#215/265
Trading
Volume	598,320 shares	US#1,620/3,116 Sec#165/265
Trading Value	$6M	US#2,360/3,116 Sec#190/265
Per Share
EPS	$-0.64	US—/3,116 Sec—/265
BPS	$2.68	US#2,512/3,116 Sec#163/265